Safety and Pharmacokinetic Characteristics of HD203 Liquid in Healthy Male Volunteers

A Randomized, Double-blind, Single-dosing, Crossover Study to Compare the Safety and Pharmacokinetic Characteristics of HD203 25 mg With Those of Enbrel® Injection 25 mg After Subcutaneous Injection in Healthy Male Volunteers

The purpose of this study is to compare the safety and pharmacokinetic characteristics of HD203 liquid with those of etanercept (enbrel) prefilled injection after subcutaneous injection

Inclusion Criteria:

• 20 to 40 years of healthy volunteers

Exclusion Criteria:

• Subject who had been treated with Etanercept before